Healthy Japanese
Conditions
Interventions
<
Duration>
Test 1: Plasmalogen derived from sea squirt Test 2: Placebo <
Take one tablet. *If you forget to take the test food, take it as soon as you remember. The daily dose should be taken within the day and not carried over to the next day. *The intervention sequen
Test 1: Placebo Test 2: Plasmalogen derived from sea squirt <
Sponsors
NIHON PHARMACEUTICAL CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese 2. Men or women 3. Adults 4. Healthy individuals
Exclusion criteria
Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 5. Individuals who are taking or using medications (including herbal medicines) or supplements 6. Individuals who take supplements related to improving cognitive functions, such as docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), ginkgo leaf extract, tocotrienol, astaxanthin, gamma-aminobutyric acid (GABA), phosphatidylserine, or plasmalogen 7. Individuals who take blue-backed fish such as sardines, mackerel, or saury at least four times a week 8. Individuals who use devices, equipment, or applications that may affect cognitive functions (e.g., brain training puzzles or brain training games) 9. Individuals who are allergic to medicines or foods related to the test product 10. Individuals who are pregnant, lactating, or planning to become pregnant during this study 11. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study 12. Individuals who are judged as ineligible to participate in this study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The change of fatigue between pre- and post-multitasking load | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The measured values of fatigue at pre-multitasking load and post-multitasking load | — |
Countries
Japan
Contacts
Public ContactNaoko Suzuki
ORTHOMEDICO Inc. R&D Department
Outcome results
None listed